10:50 – 12:35
(GMT+3)
Session II. Fundamental research and innovation in modern cardiology
Moderators: Semitko S.P., Babunashvili A.M. Petr Bushman, O.K. Granstrem, A.V. Stonogin
10.50 - 11.05
Vladimir Shirinsky, Laboratory of Cellular Mobility, Federal State Budgetary Institution "National Medical Research Center of Cardiology", Ministry of Health of the Russian Federation, Moscow
Peptide medicines. From basic research to clinical applications
11.05 - 11.15
Alexander Viller, LLC IET Sk, Moscow
Heterogeneity of technologies for the production of coronary stents on the example of studying their magnetic properties and the characteristics of the polymer coating
11.15 - 11.30
Robert Bibilashvili, Laboratory of Genetic Engineering, Federal State Budgetary Institution "National Medical Research Center of Cardiology", Ministry of Health of the Russian Federation, Moscow
New possibilities of using genetically engineered fibrinogen in patients with COVID-19
11.30 - 11.45
Oleg Granstrem, National Bioservice, St. Petersburg
National Biobanking Platform as a Catalyst for Life Sciences
11.45 - 12.10
James Muller, Harvard School of Medicine, USA
Advances in the diagnosis of unstable coronary plaque and unstable patients: implications for clinical practice and research
12.10 - 12.25
Boris Zingerman, IPat LLC, Moscow
An innovative platform for remote monitoring and patient management, its capabilities in cardiology
12.25 – 12.35
Karin Mirzaev, Hadassah Medical, Moscow
Innovations in personalizing antiplatelet therapy for cardiovascular disease: the role of omix biomarkers
12:35 – 12.45
Yaroslav Ashikhmin, MD, PhD, cardiologist, advisor to the general director of the International Medical Cluster Foundation
Radiation biomarkers in cardiovascular risk assessment: present and future